Brett Kuenne's Colleagues at QED Therapeutics
Brett Kuenne's Contact Details
HQ
650-231-4088
650-231-4088
Location
Kalispell, Montana, United States
Kalispell, Montana, United States
Company
QED Therapeutics
QED Therapeutics
Brett Kuenne's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Brett Kuenne
Brett Kuenne currently works for QED Therapeutics.
Brett Kuenne's role at QED Therapeutics is Associate Director, Quality Systems.
Brett Kuenne's email address is ***@qedtx.com. To view Brett Kuenne's full email address, please signup to ConnectPlex.
Brett Kuenne works in the BioTech/Drugs industry.
Brett Kuenne's colleagues at QED Therapeutics are Vermali Rodriguez, Kathleen Guindon, Brian Boyles, Richard Jones II, Edward Oliva, Sudesh PhD, Quoc M. and others.
Brett Kuenne's phone number is 650-231-4088